Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
N-acyl taurines and acylcarnitines cause an imbalance in insulin synthesis and secretion provoking β cell dysfunction in type 2 diabetes.
Cell Metab. 25, 1334-1347.e4 (2017)
The processes contributing to β cell dysfunction in type 2 diabetes (T2D) are uncertain, largely because it is difficult to access β cells in their intact immediate environment. We examined the pathophysiology of β cells under T2D progression directly in pancreatic tissues. We used MALDI imaging of Langerhans islets (LHIs) within mouse tissues or from human tissues to generate in situ-omics data, which we supported with in vitro experiments. Molecular interaction networks provided information on functional pathways and molecules. We found that stearoylcarnitine accumulated in β cells, leading to arrest of insulin synthesis and energy deficiency via excessive β-oxidation and depletion of TCA cycle and oxidative phosphorylation metabolites. Acetylcarnitine and an accumulation of N-acyl taurines, a group not previously detected in β cells, provoked insulin secretion. Thus, β cell dysfunction results from enhanced insulin secretion combined with an arrest of insulin synthesis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
18.164
2.941
38
59
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Langerhans Islets ; Maldi Imaging Mass Spectrometry ; Maldi-ft-icr ; N-acyl Taurines ; Acylcarnitines ; Diabetes Type 2 ; Pathophysiology ; β Cells; Imaging Mass-spectrometry; Metabolic-regulation; Glucose-tolerance; Pancreatic-islets; Resistance; Muscle; Mechanisms; Physiology; Expression; Obesity
Sprache
englisch
Veröffentlichungsjahr
2017
HGF-Berichtsjahr
2017
ISSN (print) / ISBN
1550-4131
e-ISSN
1932-7420
Zeitschrift
Cell Metabolism
Quellenangaben
Band: 25,
Heft: 6,
Seiten: 1334-1347.e4
Verlag
Elsevier
Verlagsort
Cambridge
Begutachtungsstatus
Peer reviewed
Institut(e)
Research Unit Analytical Pathology (AAP)
Institute of Computational Biology (ICB)
Institute of Diabetes and Obesity (IDO)
Institute of Experimental Genetics (IEG)
CF Pathology & Tissue Analytics (CF-PTA)
Institute of Computational Biology (ICB)
Institute of Diabetes and Obesity (IDO)
Institute of Experimental Genetics (IEG)
CF Pathology & Tissue Analytics (CF-PTA)
POF Topic(s)
30205 - Bioengineering and Digital Health
30201 - Metabolic Health
90000 - German Center for Diabetes Research
30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
90000 - German Center for Diabetes Research
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er)
Enabling and Novel Technologies
Helmholtz Diabetes Center
Genetics and Epidemiology
Helmholtz Diabetes Center
Genetics and Epidemiology
PSP-Element(e)
G-500390-001
G-554100-001
G-503800-001
G-502200-001
G-500600-001
G-501900-063
G-501900-062
A-630600-001
G-554100-001
G-503800-001
G-502200-001
G-500600-001
G-501900-063
G-501900-062
A-630600-001
WOS ID
WOS:000402961500013
Scopus ID
85020477611
PubMed ID
28591636
Erfassungsdatum
2017-06-13